A new era in Emzor Pharmaceuticals as founder begins pre retirement process

A new era in Emzor Pharmaceuticals as founders begins pre retirement process

By ETIM ETIM

By the time I started my career in journalism in Lagos in late 1980s, Emzor Pharmaceuticals was already an established name in the nation’s healthcare.

Together with other known names like Juli Pharmacy, Beecham and a few other foreign companies, Emzor played key roles, not only in the health sector, but also in the manufacturing industry.

The introduction of SAP in 1986 was a turning point in Nigeria’s industrial sector. Foreign currencies were scarce and so it was difficult for manufacturers to import raw materials.

But Emzor’s founder and CEO was indefatigable. The company continued to grow from strength to strength.

Its location in the same Isolo industrial zone as The Guardian newspaper made it easier for us to visit and cover the company’s activities regularly.

I am therefore pleased to note that after nearly five decades of pioneering leadership, Dr. Stella Chinyelu Okoli has officially stepped down from her day-to-day operational role as the Group Managing Director of Emzor Pharmaceutical Industries.

Passing the baton to Pharmacist Uzoma Ezeoke, Dr. Okoli will retain her position as the company’s Founder and Chief Executive Officer, shifting her focus toward high-level corporate strategy and mentorship. This transition marks a monumental era for the indigenous manufacturing giant. It’s also the beginning of a pre retirement process for the amazon and the iconic African.

The remarkable journey of Emzor began in January 1977, when Dr. Okoli opened a modest retail chemist outlet in Shomolu, Lagos. Driven by a vision to provide everyday Nigerians with affordable, high-quality local healthcare, she expanded into manufacturing and incorporated Emzor Pharmaceutical Industries in 1984. Today, the multi-billion Naira enterprise manufactures over 140 healthcare products, including its household flagship brand, Emzor Paracetamol. Under her leadership, the company is currently finalizing a massive ₦35 billion Active Pharmaceutical Ingredient (API) factory in Sagamu, which will make Emzor the first company in sub-Saharan Africa to locally manufacture raw malaria treatments and drastically reduce the continent’s reliance on foreign imports.

Born in Kano to a devout Igbo family from Nnewi, Anambra State, Dr. Okoli’s journey into pharmaceutical excellence was forged through world-class academic preparation. She traveled to the United Kingdom to earn her Bachelor’s degree in Pharmacy from the University of Bradford and completed her postgraduate Master’s degree in Biopharmaceuticals at the University of London. Her exceptional contributions to industrial development and national healthcare have earned her numerous accolades, including the national honor of Officer of the Order of the Niger (OON) and the prestigious ECOWAS International Gold Award.

Dr. Stella Chinyelu Okoli’s legacy remains an exceptional blueprint of resilience, proving how an indigenous, women-led enterprise can rise from a small retail shop to completely redefine the pharmaceutical landscape of an entire continent.

Share

Leave a Reply

Your email address will not be published. Required fields are marked *